New research team to target secondary lymphoedema

A NEW research partnership will look to find answers about a common cancer treatment side effect.
The partnership between Macquarie University and GenesisCare, will investigate the risks and management options of lymphoedema in cancer patients.
The team will work to develop evidence-based protocols for improved identification and management of the condition.
Lymphoedema is the term for the accumulation of excessive amounts of protein-rich fluid, causing swelling in one or multiple pa…

Click here to view the original article.